NATA TGA IVD Information Session 2 Data ~ment approach including Companion Diagnostics Published 2024-04-15 Download video MP4 360p Recommendations 28:42 NATA TGA IVD Information Session 3 Introduction of new in house IVD notification form 27:24 N43 Adverse Event Terminology Codes - Pilot Training 51:40 TGA digital transformation webinar - making it easier and faster to do business with us 53:09 Unique Device Identifier Webinar #17. 04:46 Monoclonal antibodies in medicine 40:32 Insights from the TGA Good Clinical Practice (GCP) Inspection Program 18:20 Lightning Presentation: Danaher & University of Oxford Beacon for Sepsis Subtyping Innovation 1:18:45 Prescribing therapeutic vapes: overview of the regulatory changes 52:08 Considerations for Companion Diagnostics: Lessons Learned and Key Takeaways from DIA 2024 52:41 Unique Device Identification Webinar #18 27:29 Presentation: updates to CTN form and first-in-human high-risk medical device clinical trials 1:18:45 Webinar - Prescribing therapeutic vapes overview of the regulatory changes 1:02:48 The Final Episode of CHEF AJ LIVE! Q & A with NYT Bestselling Author Dr. Joel Fuhrman - Episode 2078 54:15 UDI Webinar #19 - UDI project update and real-world benefits of UDI in healthcare 06:07 Data and Medicine 1:01:59 E175 - "CAT"-ASTROPHIC Diagnosis with Addison's Disease 14:13 Seconds from Cardiac Arrest - Case Study in Hyperkalemia 29:08 Pharmacovigilance responsibilities of medicine sponsors 07:43 How to use the Special Access Scheme and Authorised Prescriber portal to access vapes 01:35 In Vitro Diagnostics (IVD) - Reagent and Sample Dosing